AE Wealth Management »

Hcw Biologics shares owned by AE Wealth Management

Quarter-by-quarter ownership of Hcw Biologics (HCWB) shares owned by AE Wealth Management from 13F filings

Historical chart of AE Wealth Management investment in Hcw Biologics

Tip: Access up to 7 years of quarterly data

All positions including Hcw Biologics held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hcw Biologics by AE Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 30k 1.10

More positions owned by AE Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Rus Tp200 Gr Etf (IWY)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Aim Etf Products Trust Us Lrgcp B20 Jan (JANW)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus Tp200 Vl Etf (IWX)

View all positions for AE Wealth Management

Top funds holding Hcw Biologics

HighTower Advisors
Honkamp Krueger Financial Services
Pullen Investment Management
BlackRock
Vanguard Group
AE Wealth Management
Two Sigma Investments
Citadel Advisors
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Hcw Biologics